News

Identifying the correct uveitis type can help reveal underlying systemic infections, neoplastic conditions, and other ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...
HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...
The first bladder transplant in a living patient is the successful result of years of research and surgical innovation.
South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research funding over the next five years due to the aid cuts, which affect not ...
An Idaho doctor and ACLU challenge a law cutting benefits for undocumented immigrants, risking health of HIV patients and raising public health concerns.
In a recent landmark study, scientists have unveiled how HIV-1 penetrates the cell's nuclear barrier—a discovery that could reshape antiviral strategies. The research, led by Professor Peijun Zhang, ...
Government officials and employees who discriminate against persons living with the human immunodeficiency virus (HIV) face disciplinary measures, guidelines by the Civil Service Commission (CSC) ...
Health department to distribute monthly nutrition supplements to PLHIV and children, funeral assistance, educational scholarships, and PCA for PACS staff.
Fourth District Judge Amanda Brailsford in Boise on Thursday also granted provisional class-action status to a lawsuit ...
Acquired immune deficiency syndrome, or AIDS, caused by the human immunodeficiency virus (HIV), weakens the body's immune ...
Embattled CytoDyn and key ex-executives must face an investor lawsuit claiming the company knowingly misled shareholders about the status of its FDA application for leronlimab as a potential t ...